Butterfly Network Gross Margin 2020-2024 | BFLY
Butterfly Network Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2024-12-31 | $0.08B | $0.05B | 59.76% |
2024-09-30 | $0.08B | $0.02B | 28.57% |
2024-06-30 | $0.07B | $0.02B | 26.76% |
2024-03-31 | $0.07B | $0.02B | 25.00% |
2023-12-31 | $0.07B | $0.02B | 24.62% |
2023-09-30 | $0.07B | $0.04B | 58.21% |
2023-06-30 | $0.07B | $0.04B | 56.94% |
2023-03-31 | $0.07B | $0.04B | 56.16% |
2022-12-31 | $0.07B | $0.04B | 54.05% |
2022-09-30 | $0.07B | $0.04B | 51.35% |
2022-06-30 | $0.07B | $0.02B | 31.88% |
2022-03-31 | $0.07B | $0.02B | 28.36% |
2021-12-31 | $0.06B | $0.02B | 26.98% |
2021-09-30 | $0.06B | $0.02B | 30.00% |
2021-06-30 | $0.06B | $-0.05B | -83.64% |
2021-03-31 | $0.05B | $-0.05B | -108.00% |
2020-12-31 | $0.05B | $-0.06B | -129.79% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.581B | $0.082B |
Butterfly Network Inc. created handheld, single-probe whole-body ultrasound system, Butterfly iQ. The company through its proprietary Ultrasound-On-Chip(TM) technology, Butterfly Network is paving the way for earlier detection and remote management of health conditions. Butterfly Network Inc., formerly known as Longview Acquisition Corp., is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $39.499B | 54.56 |
Hims & Hers Health (HIMS) | United States | $14.471B | 150.35 |
Tempus AI (TEM) | United States | $11.278B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.503B | 70.36 |
IRhythm Technologies (IRTC) | United States | $4.501B | 0.00 |
Privia Health (PRVA) | United States | $3.050B | 208.50 |
Enovis (ENOV) | United States | $2.060B | 11.48 |
Clover Health Investments (CLOV) | United States | $1.807B | 0.00 |
Schrodinger (SDGR) | United States | $1.722B | 0.00 |
Phreesia (PHR) | United States | $1.510B | 0.00 |
Omnicell (OMCL) | United States | $1.310B | 23.11 |
Azenta (AZTA) | United States | $1.258B | 58.45 |
10x Genomics (TXG) | United States | $1.156B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
Talkspace (TALK) | United States | $0.499B | 149.00 |
Veradigm (MDRX) | United States | $0.455B | 0.00 |
Claritev (CTEV) | United States | $0.450B | 0.00 |
Standard BioTools (LAB) | United States | $0.410B | 0.00 |
TruBridge (TBRG) | United States | $0.376B | 834.67 |
Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.197B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.142B | 0.00 |
Pulmonx (LUNG) | United States | $0.138B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
CareCloud (CCLD) | United States | $0.089B | 3.39 |
Outset Medical (OM) | United States | $0.070B | 0.00 |
111 (YI) | China | $0.068B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
HeartBeam (BEAT) | United States | $0.052B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
Zhongchao (ZCMD) | China | $0.032B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
Precipio (PRPO) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Movano (MOVE) | United States | $0.007B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |